Evaluation of Combined Vaccinia Virus–mediated Antitumor Gene Therapy With P53, IL-2, and IL-12 in a Glioma Model

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700252
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Combined Therapy With Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model

PLoS ONE
Multidisciplinary
2012English

Target Therapy With Vaccinia Virus Harboring IL-24 for Human Breast Cancer

Journal of Cancer
Oncology
2020English

Serum Cytokine of Il-2, Il-10 and Il-12 Levels in Patients With Stomach Adenocarcinoma

Arquivos de Gastroenterologia
Gastroenterology
2018English

Dendritic Cells Infected With a Vaccinia Virus Interleukin-2 Vector Secrete High Levels of IL-2 and Can Become Efficient Antigen Presenting Cells That Secrete High Levels of the Immunostimulatory Cytokine IL-12

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2003English

Il-12; Il-23

Science-Business eXchange
2012English

IL-2 Antibodies in Type 1 Diabetes and During IL-2 Therapy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18

Journal of Immunology
AllergyImmunology
2003English

Locally Produced IL-10 Limits Cutaneous Vaccinia Virus Spread

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2016English

Fusogenic Activity of Vesicular Stomatitis Virus Glycoprotein Plasmid in Tumors as an Enhancer of IL-12 Gene Therapy

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy